Cargando…
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice
Angiotensin-converting enzyme 2 (ACE2) is the established cellular receptor for SARS-CoV-2. However, it is unclear whether ACE1 inhibitors (e.g., lisinopril) or angiotensin receptor blockers (e.g., losartan) alter tissue ACE2 expression. This study sought to determine whether lisinopril or losartan,...
Autores principales: | Brooks, Steven D., Smith, Rachel L., Moreira, Aline S., Ackerman, Hans C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961328/ https://www.ncbi.nlm.nih.gov/pubmed/35359831 http://dx.doi.org/10.3389/fphar.2022.798349 |
Ejemplares similares
-
Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
por: Medhora, Meetha, et al.
Publicado: (2021) -
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
por: Bækdal, Tine A., et al.
Publicado: (2019) -
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line
por: Scisciola, Lucia, et al.
Publicado: (2022) -
Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021) -
Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers
por: Misaka, Shingen, et al.
Publicado: (2020)